Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Ordinary shares, par value NIS 0.0000769 per share
-
Shares outstanding
-
45,504,462
-
Total 13F shares
-
2,579,003
-
Share change
-
+9,841
-
Total reported value
-
$1,870,234
-
Put/Call ratio
-
0.93%
-
Price per share
-
$0.72
-
Number of holders
-
11
-
Value change
-
+$4,206
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q3 2023
As of 30 Sep 2023,
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,579,003 shares.
The largest 10 holders included
Knoll Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, PNC Financial Services Group, Inc., HighTower Advisors, LLC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, UBS Group AG, and GROUP ONE TRADING, L.P..
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.